|
FEDERAL FUNDING OPPORTUNITIES
(New!) All of Us Research Program Funding Opportunity
Purpose: to speed up health research discoveries, enabling new kinds of individualized health care. To make this possible, the program is building one of the world’s largest and most diverse databases for health research. The program seeks for its participant cohort to reflect the diversity of the United States and its territories and to include individuals from groups that have been underrepresented in health research in the past.
Deadline: December 2, 2024
Learn More and Apply >>
(New!) Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Purpose: to provide support to promote research efforts on the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health.
Letter of Intent: January 5, 2025
Applications: February 5, 2025
Learn More and Apply >>
(New!) National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Purpose: to provide support to promote research efforts on early phase investigator-initiated clinical trials on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of the NCI's DCTD and OHAM.
Letter of Intent: January 5, 2025
Applications: February 5, 2025
Learn More and Apply >>
(New!) NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional) (PAR-25-078)
Purpose: to provide support to well-defined projects in any area of cancer research using the NIH R03 small grant mechanism.
Deadline: February 24, 2025
Learn More and Apply >>
(New!) The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Purpose: to provide support to promote research efforts on the use of integrative systems-level approaches to address a defined gap in metastasis research.
Letter of Intent: May 20, 2025
Applications: June 20, 2025
Learn More and Apply >>
Notice of Funding Opportunity: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
Purpose: to provide support to applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression. It is anticipated that this program will support fundamental studies designed to identify and define the molecular mechanisms through which lipid metabolism mediates tumor growth and progression, focusing specifically on the central role lipids play in linking diet with the biology of cancer; bridge the historically divided fields of nutrition and molecular metabolism; and stimulate research and tool development in this emerging area, which faces particular challenges because of the complexity of lipid biochemistry.
Deadline: February 14, 2025
Learn More and Apply >>
Notice of Funding Opportunity: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Purpose: to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful.
Deadline: February 16, 2025
Learn More and Apply >>
Notice of Funding Opportunity: Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Purpose: to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, or treatment of cancer.
Deadline: February 5, 2025
Learn More and Apply >>
Notice of Funding Opportunity: Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Purpose: to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, digital health and data science, and implementation science.
Deadline: February 5, 2025
Learn More and Apply >>
Notice of Special Interest: Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control
Purpose: to support ongoing developments in obesity prevention indicate that using multiple policy, systems, and environmental (PSE) approaches across the diverse sectors that influence obesity offer considerable promise, but few efforts have been made to carefully evaluate such whole of systems, or PSE, approaches. Foundational work is needed to help set the stage for investigators from academic institutions, cancer centers, other research organizations, and community partners to lead collaborative groups to organize, implement, and evaluate such approaches. Furthermore, determining which specific combination of PSE approaches are most appropriate for a specific community requires significant preparatory work.
Deadline: February 3, 2025
Learn More and Apply >>
Notice of Funding Opportunity: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Purpose: eligible academic and research institutions to apply for funding to modernize existing or construct new biomedical research facilities. Applications will be accepted from public and private nonprofit institutions of higher education, as well as from non-profit research organizations. Applications from both research-intensive institutions and Institutions of Emerging Excellence (IEE) in biomedical research from all geographic regions in the nation are strongly encouraged.
Letter of Intent: December 16, 2024
Learn More and Apply >>
Notice of Special Interest: Conferences and Scientific Meetings in Cancer Biology
Purpose: Support innovative conferences, symposia, and workshops that explore basic, fundamental questions in areas of cancer biology
Deadline: December 12, 2024
Learn More and Apply >>
| 
